Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 7.99 is 33% below its 5-year average of 11.99, near the low end of its 5-year range (0.00–34.46).
As of the fiscal period ended Tuesday, June 30, 2026. 8.59% below its 12-month average of 8.74.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 7.99.
CURRENT RATIO
7.99
CURRENT RATIO AVG TTM
8.74
CURRENT RATIO AVG 3Y
11.00
CURRENT RATIO AVG 5Y
11.99
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-8.59%
CURRENT VS 3Y AVG
-27.36%
CURRENT VS 5Y AVG
-33.35%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 530 covered companies
CURRENT VS SECTOR MEDIAN
+138.23%
vs the sector median at left
Acrivon Therapeutics, Inc. Common Stock
Market Cap
$87.10M
Current Ratio
7.99
TTM Avg
8.74
3Y Avg
11.00
5Y Avg
11.99
Market Cap
$85.83M
Current Ratio
7.03
TTM Avg
3.05
3Y Avg
3.90
5Y Avg
4.20
Market Cap
$81.54M
Current Ratio
1.98
TTM Avg
0.65
3Y Avg
1.44
5Y Avg
2.62
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Acrivon Therapeutics, Inc. Common Stock (ACRV) | $87.10M | 7.99 | 8.74 | 11.00 | 11.99 |
| Citius Oncology, Inc. (CTOR)vs › | $85.52M | 0.73 | 0.45 | 0.43 | 0.43 |
| Humacyte, Inc. (HUMA)vs › | $84.52M | 6.21 | 3.04 | 4.62 | 7.16 |
| Cognition Therapeutics, Inc. (CGTX)vs › | $85.83M | 7.03 | 3.05 | 3.90 | 4.20 |
| CareCloud, Inc. (CCLD)vs › | $87.54M | 1.02 | 1.16 | 1.22 | 1.27 |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $81.54M | 1.98 | 0.65 | 1.44 | 2.62 |
| Cardiff Oncology, Inc. (CRDF)vs › | $88.63M | 3.30 | 5.38 | 8.10 | 12.75 |
| Conexeu Sciences Inc. (CNXU)vs › | $87.50M | N/A | N/A | N/A | N/A |
| ImmuCell Corporation (ICCC)vs › | $89.11M | 4.75 | 3.83 | 3.74 | 4.48 |
| LENSAR Inc (LNSR)vs › | $81.80M | 2.39 | 1.97 | 2.72 | 3.82 |
Current Ratio
7.99
Quick Ratio
7.99
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 7.99 |
| 2026-03-31 | 8.98 |
| 2025-12-31 | 7.69 |
| 2025-09-30 | 8.75 |
| 2025-06-30 | 10.31 |
| 2025-03-31 | 11.17 |
| 2024-12-31 | 10.55 |
| 2024-09-30 | 12.75 |
| 2024-06-30 | 16.16 |
| 2024-03-31 | 12.40 |
| 2023-12-31 | 9.75 |
| 2023-09-30 | 15.54 |
| 2023-06-30 | 21.84 |
| 2023-03-31 | 21.82 |
| 2022-12-31 | 20.27 |
| 2022-09-30 | 12.31 |
| 2022-06-30 | 19.58 |
| 2022-03-31 | 0.00 |
| 2021-12-31 | 34.46 |
| 2021-09-30 | 0.00 |
